These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31772025)

  • 21. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carcinosarcomas of the uterus: molecular-genetic and morphological features].
    Levitskaia NV; Pozharisskiĭ KM; Vostriukhina OA; Alekseeva LN; Nemtsova MV; Matrosova IV; Kharitonova TV; Poddubnaia IV
    Arkh Patol; 2012; 74(1):7-11. PubMed ID: 22712296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
    Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
    PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
    Murray SK; Clement PB; Young RH
    Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.
    McConechy MK; Hoang LN; Chui MH; Senz J; Yang W; Rozenberg N; Mackenzie R; McAlpine JN; Huntsman DG; Clarke BA; Gilks CB; Lee CH
    J Pathol Clin Res; 2015 Jul; 1(3):173-85. PubMed ID: 27499902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.
    Inoue H; Hashimura M; Akiya M; Chiba R; Saegusa M
    Mol Cancer; 2017 Feb; 16(1):37. PubMed ID: 28193280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPP2R1A mutations are common in the serous type of endometrial cancer.
    Nagendra DC; Burke J; Maxwell GL; Risinger JI
    Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.
    Xiao G; Li Y; Wang M; Li X; Qin S; Sun X; Liang R; Zhang B; Du N; Xu C; Ren H; Liu D
    Cell Prolif; 2018 Oct; 51(5):e12473. PubMed ID: 30094882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN mutations in uterine sarcomas.
    Amant F; de la Rey M; Dorfling CM; van der Walt L; Dreyer G; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Gynecol Oncol; 2002 Apr; 85(1):165-9. PubMed ID: 11925138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
    Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
    Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
    [No Abstract]   [Full Text] [Related]  

  • 35. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
    Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
    Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
    PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological features of uterine carcinosarcoma: A retrospective study of 20 cases with an emphasis on the usefulness of endometrial cytology.
    Okano K; Ishida M; Sandoh K; Mizokami T; Kita M; Okada H; Tsuta K
    Diagn Cytopathol; 2019 Jun; 47(6):547-552. PubMed ID: 30706679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.